Free Trial

eFFECTOR Therapeutics (EFTR) SEC Filings & 10K Form

$0.06
-0.02 (-25.22%)
(As of 03:40 PM ET)

Recent eFFECTOR Therapeutics SEC Filings

DateFilerForm TypeView
06/25/2024
7:30 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:16 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
6:06 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:45 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:45 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:23 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:25 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:35 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:15 PM
Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
5:19 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Gallagher Brian M. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
7:36 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:51 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
05/09/2024
3:06 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:08 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2024
5:05 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form DEF 14A
04/26/2024
5:10 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form DEFA14A
04/26/2024
5:14 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form ARS
04/16/2024
7:00 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form PRE 14A
04/04/2024
7:38 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:40 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
04/04/2024
7:15 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B5
04/02/2024
11:15 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form EFFECT
03/29/2024
1:51 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form POS AM
03/28/2024
3:02 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2024
7:57 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2024
3:10 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
4:39 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:20 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:22 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:25 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
4:27 PM
Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
2:48 PM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
PFIZER INC (Filed by)
Form SC 13G/A
02/14/2024
8:48 AM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
Form SC 13G/A
02/09/2024
7:14 PM
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/30/2024
7:31 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
7:01 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
7:06 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
01/08/2024
7:19 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
01/08/2024
7:15 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:23 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
7:23 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This is HOW many elite traders think (Ad)

Want a preview of how elite traders think?! For a limited time, you can claim AI SMS alerts from TradeAlgo for FREE.

So, hurry and click here to claim your FREE SMS alerts now.
12/08/2023
7:31 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
12/08/2023
7:31 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
11/29/2023
4:07 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
George Simeon (Reporting)
SR One Capital Fund I Aggregator LP (Reporting)
SR ONE CAPITAL MANAGEMENT, LLC (Reporting)
SR ONE CAPITAL PARTNERS I, LP (Reporting)
SR One Co-Invest I Manager, LLC (Reporting)
SR One Co-Invest I, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
7:15 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
7:18 AM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
11/22/2023
3:16 PM
COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Form SC 13D/A
11/16/2023
4:30 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
4:26 PM
Byrnes Michael (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:33 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
11/13/2023
3:23 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:25 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/15/2023
3:05 PM
COLUMN GROUP II, LP (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Form SC 13D/A
09/11/2023
6:36 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2023
6:38 PM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
3:58 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 424B3
09/11/2023
3:51 PM
eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2023
3:16 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Form SC 13D/A
08/14/2023
7:00 AM
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EFTR) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners